CLINICAL_TRIALS
trial_result
· 2021-12-02
Clinical Trial Update: HeartMate 3 CE Mark Study Long Term Follow-up
Summary
Long-term follow-up results from the HeartMate 3 CE Mark study in patients with advanced refractory left ventricular heart failure have completed and results we…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Advanced Refractory Left Ventricular Heart Failure | Status: COMPLETED | Results posted: 2021-12-02